New melatonin-N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
about
Recent Advances in Neurogenic Small Molecules as Innovative Treatments for Neurodegenerative DiseasesTherapeutic uses of melatonin and melatonin derivatives: a patent review (2012 - 2014).Discovery of novel PDE9 inhibitors capable of inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer's disease.Hybrids: a new paradigm to treat Alzheimer's disease.Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration.New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition.Synthesis and characterization of new bivalent agents as melatonin- and histamine H3-ligands.Melatonin antagonizes interleukin-18-mediated inhibition on neural stem cell proliferation and differentiation3-Amidocoumarins as Potential Multifunctional Agents against Neurodegenerative Diseases.Optimization of Bicyclic Lactam Derivatives as NMDA Receptor Antagonists.Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids.Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
P2860
Q28069509-1CBA5AE0-3746-4960-AC88-616C76C80262Q34457651-DBEB2776-FEC6-4815-A551-D85C8609C2F9Q36615734-A37D0DFD-D40A-4AF9-AE1C-DC312CD23BCEQ38578336-42029258-5BE8-4DD7-B135-2CE630098D62Q38684594-3E033AD9-2F88-4F0E-A16D-3040BBF2B984Q38842928-1C0FCF7A-4B12-4213-B539-7DCB34220CAAQ39128977-1A68FF60-87C9-4B7B-B8B7-77F237FA8797Q41520482-1FD25685-203C-4E7F-8C76-22301043E3DDQ46650139-9795045C-7C6F-4A9F-A38A-49546732DCF5Q48218430-6FB3F338-4F1B-45EC-A7B6-21E4AFB8E1A9Q48401352-F1FD4D03-94CC-4721-8682-7E4D1BF145A6Q48636523-8B5DDD2B-81A1-40EB-8265-19B62CE7E16A
P2860
New melatonin-N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
New melatonin-N,N-dibenzyl(N-m ...... drugs for Alzheimer's disease.
@ast
New melatonin-N,N-dibenzyl(N-m ...... drugs for Alzheimer's disease.
@en
type
label
New melatonin-N,N-dibenzyl(N-m ...... drugs for Alzheimer's disease.
@ast
New melatonin-N,N-dibenzyl(N-m ...... drugs for Alzheimer's disease.
@en
prefLabel
New melatonin-N,N-dibenzyl(N-m ...... drugs for Alzheimer's disease.
@ast
New melatonin-N,N-dibenzyl(N-m ...... drugs for Alzheimer's disease.
@en
P2093
P50
P356
P1476
New melatonin-N,N-dibenzyl(N-m ...... drugs for Alzheimer's disease.
@en
P2093
Beatriz López-Iglesias
Concepción Pérez
Mercedes Villarroya
Sandra Alonso-Gil
Santiago Conde
P304
P356
10.1021/JM5000613
P407
P50
P577
2014-04-28T00:00:00Z